(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

STOWERS INSTITUE FOR MEDICAL RESEARCH

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: US

Quick snapshot

STOWERS INSTITUE FOR MEDICAL RESEARCH

ST13

US500000075656764

Class

42

Filing

75656764

Registration

2403448

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

Attention: there is active risk

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

30

Latest update

10/19/2020

Classification

Registered

Trademark type

Combined

Nice classes

42

Filing date

03/09/1999

Registration date

11/14/2000

Expiration date

-

Recommended action

Perform a full collision analysis and validate classes before any filing or trademark investment.

Next step

These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/19/2020

Last transaction

10/19/2020

Responsible office

United States Patent and Trademark Office

Status code

800

Official register

Principal Register

First use anywhere

04/01/1998

First use in commerce

04/01/1998

Drawing code

3

Owner type

54

Owner location

Kansas City, MO

Examiner

AYALA, LOURDES

Law office

L60

Current location

GENERIC WEB UPDATE

Holders and representatives

Holders

Stowers Institute for Medical Research

Representatives

Matthew G. Minder Bryan Cave Leighton Paisner LLP

Technical classification

Nice Classes

Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 42

Medical research servicesconducting research into complex genetic systems to find cures or improved treatments for cancerarthritis and other diseases

Publications

History of USPTO decisions and trademark events.

30 publications found

NA89

NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED

10/19/2020

RNL2

REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)

10/19/2020

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

10/19/2020

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

09/30/2020

E89R

TEAS SECTION 8 & 9 RECEIVED

08/19/2020

REM2

COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED

11/14/2019

RNL1

REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)

08/24/2010

89AG

REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED

08/24/2010

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

08/23/2010

E89R

TEAS SECTION 8 & 9 RECEIVED

08/12/2010

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/12/2010

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/12/2010

ASCK

ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY

02/12/2009

MDSC

NOTICE OF DESIGN SEARCH CODE MAILED

11/07/2008

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

08/29/2007

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

08/29/2007

C15A

REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.

01/04/2007

815F

REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED

10/30/2006

E815

TEAS SECTION 8 & 15 RECEIVED

10/30/2006

CFIT

CASE FILE IN TICRS

08/03/2006

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/17/2006

R.PR

REGISTERED-PRINCIPAL REGISTER

11/14/2000

PUBO

PUBLISHED FOR OPPOSITION

08/22/2000

NPUB

NOTICE OF PUBLICATION

07/21/2000

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/21/2000

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

05/19/2000

CNRT

NON-FINAL ACTION MAILED

01/14/2000

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

11/10/1999

CNRT

NON-FINAL ACTION MAILED

09/09/1999

DOCK

ASSIGNED TO EXAMINER

08/30/1999

Continuous trademark protection

Get notified about every new filing that threatens STOWERS INSTITUE FOR MEDICAL RESEARCH or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.